Title : Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non-small-cell lung cancer.

Pub. Date : 2020 Apr

PMID : 31778239






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 WHAT IS KNOWN AND OBJECTIVE: Erlotinib is a small molecule tyrosine kinase inhibitor which blocks the activation of epidermal growth factor receptor (EGFR), a transmembrane receptor that is upregulated in many cancer types. erlotinib epidermal growth factor receptor Homo sapiens
2 WHAT IS KNOWN AND OBJECTIVE: Erlotinib is a small molecule tyrosine kinase inhibitor which blocks the activation of epidermal growth factor receptor (EGFR), a transmembrane receptor that is upregulated in many cancer types. erlotinib epidermal growth factor receptor Homo sapiens